title: Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets.
abstract: The interaction between porcine circovirus type 2 (PCV2) and the pig immune system has been suggested to be a determinant event for the pathogenesis of postweaning multisystemic wasting syndrome (PMWS). To gain insight into the host immune mechanisms developed upon PCV2 infection, early innate and adaptive immune responses were examined in 1-week-old, caesarean-derived, colostrum-deprived piglets using a subclinical infection model of PCV2 in combination with lipopolysaccharide (LPS) as a potential immunostimulation factor. The use of LPS did not show any significant effect on the course of PCV2 infection, nor did in the evolution of the immunological parameters evaluated. Ex vivo responses were detected as early as 1 day post-infection (PI) and consisted of an elevation of the plasmatic levels of interleukin (IL)-8 in PCV2-inoculated pigs followed by an increase on plasmatic IFN-alpha at day 5 PI. Regarding IL-10, only one PCV2-inoculated pig was positive (day 7 PI); this pig was the only one in which viremia persisted until the end of the study. In vitro cytokine determination showed that, regardless of the treatment administrated to the pigs, an IL-10 release was observed when peripheral blood mononuclear cells (PBMC) cultures were stimulated with PCV2. Seroconvertion to PCV2 measured by an immunoperoxidase monolayer assay (IPMA) occurred between 7 and 14 days PI, whereas neutralizing antibodies (NA) did not appear until day 29 PI. PCV2 DNA was first detected in serum at day 7 PI, reaching the peak of viremia between days 14 and 21 PI, followed by a drop in viral load that was found coincident with the appearance of PCV2-specific IFN-gamma-secreting cells (PCV2-IFN-gamma-SC) and NA. Results from the present work suggest that viral clearance might be mediated by the development of PCV2-IFN-gamma-SC in contribution to the PCV2-specific NA.
authors.affiliation: Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, Barcelona, Spain. maria.fort@cresa.uab.cat
authors.forename: Maria
authors.initials: M
authors.lastname: Fort
authors.forename: Lana T
authors.initials: LT
authors.lastname: Fernandes
authors.forename: Miquel
authors.initials: M
authors.lastname: Nofrarias
authors.forename: Ivan
authors.initials: I
authors.lastname: Díaz
authors.forename: Marina
authors.initials: M
authors.lastname: Sibila
authors.forename: Joan
authors.initials: J
authors.lastname: Pujols
authors.forename: Enric
authors.initials: E
authors.lastname: Mateu
authors.forename: Joaquim
authors.initials: J
authors.lastname: Segalés
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D018173:Circoviridae Infections / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D017925:Circovirus / Q000276:immunology*; D016207:Cytokines / Q000097:blood / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005434:Flow Cytometry / Q000662:veterinary; D007111:Immunity, Cellular / Q000276:immunology; D016130:Immunophenotyping / Q000662:veterinary; D008070:Lipopolysaccharides / Q000276:immunology / Q000494:pharmacology; D053570:Porcine Postweaning Multisystemic Wasting Syndrome / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D011897:Random Allocation; D013552:Swine / Q000276:immunology*; D019562:Viral Load / Q000662:veterinary
chemical_list: D016207:Cytokines; D008070:Lipopolysaccharides